These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 32502942)

  • 1. Per- and polyfluoroalkyl substances in blood plasma - Results of the German Environmental Survey for children and adolescents 2014-2017 (GerES V).
    Duffek A; Conrad A; Kolossa-Gehring M; Lange R; Rucic E; Schulte C; Wellmitz J
    Int J Hyg Environ Health; 2020 Jul; 228():113549. PubMed ID: 32502942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
    Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
    Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of per- and polyfluoroalkyl substances (PFAS) in human blood samples collected in three regions with known PFAS releases in the environment and three control regions in South Germany.
    Hron LMC; Wöckner M; Fuchs V; Fembacher L; Aschenbrenner B; Herr C; Schober W; Heinze S; Völkel W
    Arch Toxicol; 2024 Nov; 98(11):3727-3738. PubMed ID: 39167139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Per- and polyfluoroalkyl substance (PFAS) exposure assessment in a community exposed to contaminated drinking water, New Hampshire, 2015.
    Daly ER; Chan BP; Talbot EA; Nassif J; Bean C; Cavallo SJ; Metcalf E; Simone K; Woolf AD
    Int J Hyg Environ Health; 2018 Apr; 221(3):569-577. PubMed ID: 29514764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.
    Calafat AM; Wong LY; Kuklenyik Z; Reidy JA; Needham LL
    Environ Health Perspect; 2007 Nov; 115(11):1596-602. PubMed ID: 18007991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014.
    Ye X; Kato K; Wong LY; Jia T; Kalathil A; Latremouille J; Calafat AM
    Int J Hyg Environ Health; 2018 Jan; 221(1):9-16. PubMed ID: 28993126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human biomonitoring (HBM)-II values for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) - Description, derivation and discussion.
    Schümann M; Lilienthal H; Hölzer J
    Regul Toxicol Pharmacol; 2021 Apr; 121():104868. PubMed ID: 33484797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Children's exposure to perfluoroalkyl acids - a modelling approach.
    Balk FGP; Winkens Pütz K; Ribbenstedt A; Gomis MI; Filipovic M; Cousins IT
    Environ Sci Process Impacts; 2019 Nov; 21(11):1875-1886. PubMed ID: 31549993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluorinated substances in the Flemish population (Belgium): Levels and determinants of variability in exposure.
    Colles A; Bruckers L; Den Hond E; Govarts E; Morrens B; Schettgen T; Buekers J; Coertjens D; Nawrot T; Loots I; Nelen V; De Henauw S; Schoeters G; Baeyens W; van Larebeke N
    Chemosphere; 2020 Mar; 242():125250. PubMed ID: 31896205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women.
    Zhang S; Tan R; Pan R; Xiong J; Tian Y; Wu J; Chen L
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2543-2551. PubMed ID: 29986037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of 3M Cordova, IL production worker's per- and polyfluoroalkyl substances biomonitoring results and mortality experience.
    Andres KL; Olsen GW; Krisko RM; Nunnally MC; Boeding RR; Leniek KL; Taiwo OA
    Int J Hyg Environ Health; 2024 Mar; 256():114321. PubMed ID: 38244249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
    Kang H; Kim SH
    Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using 2003-2014 U.S. NHANES data to determine the associations between per- and polyfluoroalkyl substances and cholesterol: Trend and implications.
    Dong Z; Wang H; Yu YY; Li YB; Naidu R; Liu Y
    Ecotoxicol Environ Saf; 2019 May; 173():461-468. PubMed ID: 30798190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Biomonitoring (HBM)-I values for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) - Description, derivation and discussion.
    Hölzer J; Lilienthal H; Schümann M
    Regul Toxicol Pharmacol; 2021 Apr; 121():104862. PubMed ID: 33444659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Per- and polyfluoroalkyl substances (PFAS) in Australia: Current levels and estimated population reference values for selected compounds.
    Toms LML; Bräunig J; Vijayasarathy S; Phillips S; Hobson P; Aylward LL; Kirk MD; Mueller JF
    Int J Hyg Environ Health; 2019 Apr; 222(3):387-394. PubMed ID: 30898527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal trends of per- and polyfluoroalkyl substances in children's serum.
    Koponen J; Winkens K; Airaksinen R; Berger U; Vestergren R; Cousins IT; Karvonen AM; Pekkanen J; Kiviranta H
    Environ Int; 2018 Dec; 121(Pt 1):591-599. PubMed ID: 30308470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population.
    Midasch O; Schettgen T; Angerer J
    Int J Hyg Environ Health; 2006 Nov; 209(6):489-96. PubMed ID: 16872899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to per- and polyfluoroalkyl substances and age-related macular degeneration in U.S. middle-aged and older adults.
    Kang H; Park SK; Kim DH; Choi YH
    Chemosphere; 2024 Sep; 364():143167. PubMed ID: 39181460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.